The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus
Open accessAbstract
ABSTRACTObjectives:Behavioral and psychological symptoms of dementia (BPSD) are nearly universal in dementia, a condition occurring in more than 40 million people worldwide. BPSD present a considerable treatment challenge for prescribers and healthcare professionals. Our purpose was to prioritize existing and emerging treatments for BPSD in Alzheimer's disease (AD) overall, as well as specifically for agitation and psychosis. DESIGN: International Delphi consensus process. Two rounds of feedback were conducted, followed by an in-person meeting to ratify the outcome of the electronic process. SETTINGS: 2015 International Psychogeriatric Association meeting. PARTICIPANTS: Expert panel comprised of 11 international members with clinical and research expertise in BPSD management. RESULTS: Consensus outcomes showed a clear preference for an escalating approach to the management of BPSD in AD commencing with the identification of underlying causes. For BPSD overall and for agitation, caregiver training, environmental adaptations, person-centered care, and tailored activities were identified as first-line approaches prior to any pharmacologic approaches. If pharmacologic strategies were needed, citalopram and analgesia were prioritized ahead of antipsychotics. In contrast, for psychosis, pharmacologic options, and in particular, risperidone, were prioritized following the assessment of underlying causes. Two tailored non-drug approaches (DICE and music therapy) were agreed upon as the most promising non-pharmacologic treatment approaches for BPSD overall and agitation, with dextromethorphan/quinidine as a promising potential pharmacologic candidate for agitation. Regarding future treatments for psychosis, the greatest priority was placed on pimavanserin. CONCLUSIONS: This international consensus panel provided clear suggestions for potential refinement of current treatment criteria and prioritization of emerging therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“finding lower Cohen Mansfield Agitation Inventory (CMAI) at 9 months (MD −4·3 points, 95% CI −7·3 to −1·2).219”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [219]
In the citing paper
“Two new cluster RCTs of professionals delivering multicomponent, interdisciplinary, interventions in care homes successfully reduced agitation.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [219]
Citations
Cites
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247 · cited 2×
“The DICE (Describe, Investigate, Create, and Evaluate) (Kales et al., 2014; Kales et al., 2015) intervention which provides a structured approach to assessment of underlying causes, care planning including pharmacologic and non-pharmacoloic strategies and ongoing monitoring was considered to be…”
BackgroundSelf-citationCummings, J., Isaacson, S., Mills, R., Williams, H., Chi-Burris, K., Corbett, A., Dhall, R., & Ballard, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62106-6 · Cited by 954
Self-citationMaust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3018 · Cited by 617 · cited 1×
“Unfortunately, the modest benefits associated with antipsychotics must be balanced against significant safety concerns including accelerated cognitive decline, stroke, and death, particularly when used in the long term (Kales et al., 2015; Maust et al., 2015).”
BackgroundSelf-citationKales, H. C., Gitlin, L. N., Lyketsos, C. G., & Dementia, T. D. E. P. O. T. A. A. M. O. T. N. S. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12730 · Cited by 575 · cited 3×
“The DICE (Describe, Investigate, Create, and Evaluate) (Kales et al., 2014; Kales et al., 2015) intervention which provides a structured approach to assessment of underlying causes, care planning including pharmacologic and non-pharmacoloic strategies and ongoing monitoring was considered to be highest priority, follo…”
BackgroundSelf-citationHusebo, B. S., Ballard, C., Sandvik, R., Nilsen, O. B., & Aarsland, D. (2011) · BMJ · doi:10.1136/bmj.d4065 · Cited by 571 · cited 2×
“There is clinical trial evidence to support both citalopram and stepped analgesia as treatment approaches which confer improvement in agitation (Husebo et al., 2011; Husebo et al., 2014).”
BackgroundSelf-citationChenoweth, L., King, M. T., Jeon, Y.-H., Brodaty, H., Stein-Parbury, J., Norman, R., Haas, M., & Luscombe, G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70045-6 · Cited by 528 · cited 1×
“Agitation and aggression occur in approximately 20% of people with AD in contact with clinical services or living in the community (Fossey et al., 2006; Chenoweth et al., 2009).”
BackgroundFossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R., & Howard, R. (2006) · BMJ · doi:10.1136/bmj.38782.575868.7c · Cited by 512 · cited 2×
“…by robust evidence from recently published large clinical trials that have shown significant benefit to agitation following structured non-drug approaches that focus on caregiver training, person-centeredness and promotion of pleasant activities (Fossey et al., 2006; Ballard et al., 2016).”
BackgroundSelf-citationTeri, L., McCurry, S. M., Logsdon, R., & Gibbons, L. E. (2005) · The Gerontologist · doi:10.1093/geront/45.6.802 · Cited by 207 · cited 3×
“, 2015) intervention which provides a structured approach to assessment of underlying causes, care planning including pharmacologic and non-pharmacoloic strategies and ongoing monitoring was considered to be highest priority, followed by training and empowering caregivers, such as the STAR-C (Teri et al., 2005) caregi…”
BackgroundThe Response of Agitated Behavior to Pain Management in Persons with Dementia
Husebo, B. S., Ballard, C., Cohen-Mansfield, J., Seifert, R., & Aarsland, D. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.006 · Cited by 171 · cited 2×
“There is clinical trial evidence to support both citalopram and stepped analgesia as treatment approaches which confer improvement in agitation (Husebo et al., 2011; Husebo et al., 2014).”
BackgroundSelf-citationTestad, I., Corbett, A., Aarsland, D., Lexow, K. O., Fossey, J., Woods, B., & Ballard, C. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000131 · Cited by 164 · cited 1×
“However, there is an emerging evidence base that indicates that non-drug approaches exert a differential impact on psychosis and agitation, and that the selection of these approaches is critical to ensure a beneficial outcome (Testad et al., 2014).”
BackgroundSelf-citation
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Self-citationRetractedWang, H., Li, T., Barbarino, P., Gauthier, S., Brodaty, H., Molinuevo, J. L., Xie, H., Sun, Y., Yu, E., Tang, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30755-8 · Cited by 562
Dhapola, R., Hota, S. S., Sarma, P., Bhattacharyya, A., Medhi, B., & Reddy, D. H. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00889-6 · Cited by 383
Management of Behavioral and Psychological Symptoms of Dementia
Bessey, L. J., & Walaszek, A. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1049-5 · Cited by 288
Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Yan, X., Hu, Y., Wang, B., Wang, S., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.530219 · Cited by 220
Metadata
- Authors
- Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C.
- Affiliations
- University of Michigan (US)
- Johns Hopkins University (US)
- University of Exeter (GB)
- Corresponding author
- Kales, Helen C.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 31
- Issue
- 1
- Pages
- 83-90
- ISSN
- 1041-6102 (ISSN-L)
- OpenAlex
- W2885149803
- Cited by
- 220
- References
- 15
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 30 · 2023: 21 · 2022: 45 · 2021: 37 · 2020: 32 · 2019: 14
- FWCI
- 16.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2190 d)
- Locations
- International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Funders
- University of Michigan
- International Psychogeriatric Association
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- behavioral and psychological symptoms of dementia, Alzheimer's disease, agitation, psychosis, treatment prioritization, non-pharmacological treatment, caregiver education, person-centred care, antipsychotic drugs, citalopram, analgesia, risperidone, pimavanserin, dextromethorphan/quinidine, music therapy, environmental adaptation
- MeSH terms
- Alzheimer Disease, Behavioral Symptoms, Delphi Technique, Geriatric Psychiatry, Humans, International Cooperation, Music Therapy, Psychomotor Agitation, Psychotic Disorders, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. https://app.cochat.ai/papers/10.1017/s1041610218000534
- The paper
- Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C. (2019). Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. International Psychogeriatrics. https://doi.org/10.1017/s1041610218000534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.